Work

Preliminary Safety and Efficacy of Myeloablative Orca-Q in Patients with Haploidentical Donors

Year: 2026

Type: article

Study design: Clinical Trial

Source: Transplantation and Cellular Therapy

DOI: 10.1016/j.jtct.2025.12.373

Authors: Amandeep Salhotra, Samer A. Srour, Mehrdad Abedi, Edmund K. Waller, Hannah K. Choe, Anna Pavlova, Tamara Zharkevich, Scott Killian, James Scott McClellan, Nathaniel B. Fernhoff, Robert Lowsky

Institutions: City Of Hope National Medical Center, The University of Texas MD Anderson Cancer Center, UC Davis Comprehensive Cancer Center, University of California, Davis, Winship Cancer Institute, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Wexner Medical Center, Alpha Omega Alpha Medical Honor Society, Stanford Medicine, Stanford University

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7127419337

FWCI:

Cites:

Cited by:

Related to: